Login / Signup

Microbial production of 4-amino-1-butanol, a four-carbon amino alcohol.

Cindy Pricilia Surya PrabowoJae Ho ShinJae Sung ChoTong Un ChaeSang Yup Lee
Published in: Biotechnology and bioengineering (2020)
4-Amino-1-butanol (4AB) serves as an important intermediate compound for drugs and a precursor of biodegradable polymers used for gene delivery. Here, we report for the first time the fermentative production of 4AB from glucose by metabolically engineered Corynebacterium glutamicum harboring a newly designed pathway comprising a putrescine (PUT) aminotransferase (encoded by ygjG) and an aldehyde dehydrogenase (encoded by yqhD) from Escherichia coli, which convert PUT to 4AB. Application of several metabolic engineering strategies such as fine-tuning the expression levels of ygjG and yqhD, eliminating competing pathways, and optimizing culture condition further improved 4AB production. Fed-batch culture of the final metabolically engineered C. glutamicum strain produced 24.7 g/L of 4AB. The strategies reported here should be useful for the microbial production of primary amino alcohols from renewable resources.
Keyphrases
  • escherichia coli
  • microbial community
  • poor prognosis
  • drug delivery
  • type diabetes
  • pseudomonas aeruginosa
  • binding protein
  • multidrug resistant
  • skeletal muscle
  • candida albicans
  • alcohol consumption